|
| Astragaloside III Basic information |
Product Name: | Astragaloside III | Synonyms: | Astragaloside-Ⅲ;Astragaloside III;β-D-Xylopyranoside,(3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl2-O-β-D-glucopyranosyl-;ASTRAGALOSIDE III(SH);b-D-Xylopyranoside, (3b,6a,16b,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-b-D-glucopyranosyl-;Astragaloside III,98%;Balofloxacin Impurity 4 | CAS: | 84687-42-3 | MF: | C41H68O14 | MW: | 784.97 | EINECS: | | Product Categories: | chemical reagent;pharmaceutical intermediate;The group of Astralosides;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | Mol File: | 84687-42-3.mol | |
| Astragaloside III Chemical Properties |
Melting point | 245~247℃ | Boiling point | 906.8±65.0 °C(Predicted) | density | 1.39±0.1 g/cm3(Predicted) | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | solubility | Methanol (Slightly), Pyridine (Slightly) | pka | 12.89±0.70(Predicted) | form | Solid | color | White to Off-White |
| Astragaloside III Usage And Synthesis |
Description | Astragaloside III is a saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine. It is bioavailable after oral administration, distributed mainly to the thymus and spleen, and has a half-life of approximately 2 hours. | Uses | Astragaloside III has cardioprotective effects as well as causing improvement in cognitive function. Used in the prevention of cardio-cerebral vascular diseases. Antioxidant. | Definition | ChEBI: A triterpenoid saponin that is cycloastragenol with a 2-O-beta-D-glucopyranosyl-beta-D-xylopyranosyl moiety attached at position 3 via a glycosidic linkage. |
| Astragaloside III Preparation Products And Raw materials |
Raw materials | β-D-Xylopyranoside, (3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl-->Uridine 5'-(trihydrogen diphosphate), mono-alpha-d-glucopyranosyl ester |
|